Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211


Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression.

Yang XP, Yan D, Qiao C, Liu RJ, Chen JG, Li J, Schneider M, Lagrost L, Xiao X, Jiang XC.

Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1601-7.


Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis despite lower apolipoprotein B-containing lipoproteins.

Lie J, de Crom R, van Gent T, van Haperen R, Scheek L, Sadeghi-Niaraki F, van Tol A.

J Lipid Res. 2004 May;45(5):805-11.


Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein.

van Haperen R, van Tol A, van Gent T, Scheek L, Visser P, van der Kamp A, Grosveld F, de Crom R.

J Biol Chem. 2002 Dec 13;277(50):48938-43.


Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice.

Ehnholm S, van Dijk KW, van 't Hof B, van der Zee A, Olkkonen VM, Jauhiainen M, Hofker M, Havekes L, Ehnholm C.

J Lipid Res. 1998 Jun;39(6):1248-53.


Dynamic changes in mouse lipoproteins induced by transiently expressed human phospholipid transfer protein (PLTP): importance of PLTP in prebeta-HDL generation.

Jaari S, van Dijk KW, Olkkonen VM, van der Zee A, Metso J, Havekes L, Jauhiainen M, Ehnholm C.

Comp Biochem Physiol B Biochem Mol Biol. 2001 Apr;128(4):781-92.


Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E.

Jiang XC, Tall AR, Qin S, Lin M, Schneider M, Lalanne F, Deckert V, Desrumaux C, Athias A, Witztum JL, Lagrost L.

J Biol Chem. 2002 Aug 30;277(35):31850-6.


Introduction of the human PLTP transgene suppresses the atherogenic diet-induced increase in plasma phospholipid transfer activity in C57BL/6 mice.

Tu AY, Paigen B, Wolfbauer G, Cheung MC, Kennedy H, Chen H, Albers JJ.

Int J Clin Lab Res. 1999;29(1):14-21.


Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteins.

Lie J, de Crom R, Jauhiainen M, van Gent T, van Haperen R, Scheek L, Jansen H, Ehnholm C, van Tol A.

Biochem J. 2001 Dec 1;360(Pt 2):379-85.


Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.

Liu R, Hojjati MR, Devlin CM, Hansen IH, Jiang XC.

Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):190-6.


Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice.

van Haperen R, van Tol A, Vermeulen P, Jauhiainen M, van Gent T, van den Berg P, Ehnholm S, Grosveld F, van der Kamp A, de Crom R.

Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):1082-8.


Transgenic mice expressing human phospholipid transfer protein have increased HDL/non-HDL cholesterol ratio.

Albers JJ, Tu AY, Paigen B, Chen H, Cheung MC, Marcovina SM.

Int J Clin Lab Res. 1996;26(4):262-7.


Phospholipid transfer protein is regulated by liver X receptors in vivo.

Cao G, Beyer TP, Yang XP, Schmidt RJ, Zhang Y, Bensch WR, Kauffman RF, Gao H, Ryan TP, Liang Y, Eacho PI, Jiang XC.

J Biol Chem. 2002 Oct 18;277(42):39561-5.


Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes.

Colhoun HM, Taskinen MR, Otvos JD, Van Den Berg P, O'Connor J, Van Tol A.

Diabetes. 2002 Nov;51(11):3300-5.


Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.

Valenta DT, Ogier N, Bradshaw G, Black AS, Bonnet DJ, Lagrost L, Curtiss LK, Desrumaux CM.

Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1572-8.


Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis.

O'Brien KD, Vuletic S, McDonald TO, Wolfbauer G, Lewis K, Tu AY, Marcovina S, Wight TN, Chait A, Albers JJ.

Circulation. 2003 Jul 22;108(3):270-4.


Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.

Quarck R, De Geest B, Stengel D, Mertens A, Lox M, Theilmeier G, Michiels C, Raes M, Bult H, Collen D, Van Veldhoven P, Ninio E, Holvoet P.

Circulation. 2001 May 22;103(20):2495-500.


Phospholipid transfer protein.

van Tol A.

Curr Opin Lipidol. 2002 Apr;13(2):135-9. Review.

Items per page

Supplemental Content

Support Center